InvestorsHub Logo
Followers 898
Posts 149074
Boards Moderated 0
Alias Born 08/13/2010

Re: texaschris22 post# 3334

Wednesday, 03/31/2021 1:08:56 PM

Wednesday, March 31, 2021 1:08:56 PM

Post# of 6265
Pfizer upgrade to $53 $PFE The Pfizer Analyst: Cantor Fitzgerald analyst Louise Chen maintained an Overweight rating on Pfizer with a $53 price target.

The Pfizer Takeaways: The positive topline results are good news for the company, underlining Pfizer's ability to pivot and innovate quickly, Chen said in a note.

The data reinforces Cantor's positive investment thesis on the stock and view that Pfizer's pipeline is underappreciated, the analyst said.

Nothing I say, post, or do should ever be considered financial advice. I may be holding a long, short or no position. I am NOT or NEVER have I been compensated to post on here or anywhere and all my posts are for entertainment purposes only.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent PFE News